Inspections History

ËÄÉ«AV sites are periodically inspected by the local and external authorities. All sites are FDA approved and with exception of New Jersey site all have EU GMP certificates.

has inspected our sites for over 40 years (Portugal since 1982, Macau since 1987, New Jersey since 2007 and the Cork site we bought from Pfizer since 2008). As of 1982 we have been through 40 FDA inspections, primarily pre-approval inspections, 18 resulted in no Form 483 being issued, the remainder all had an approvable site letter issued promptly. Portugal, Macau and Ireland have all been inspected by EU medicines’ agencies either for human or veterinary use products. routinely inspects the Portugal site, as do other national agencies. Our Macau site is also routinely inspected by the (human products) and (veterinary products).ÌýWe are forthcoming to support regulatory developments and our sites always engage in pilot exercises with Agencies.

Each site, as a supplier of APIs, or of intermediate drug product or of drug product (for commercial or clinical trial use), has the appropriate approvals by the local medicine agency.

The sites in Portugal and New Jersey are C-TPAT certified.

Last inspections in Loures

Health Authority Date Observations Inspection Report
FDA 2024 Ìý Ìý
Ìý 2023 Ìý Ìý
Ìý 2018 Ìý view report
Ìý 2017 No form 483 view report
Ìý 2017 Ìý view report
Ìý 2016 No form 483 Ìý
Ìý 2014 Ìý view report
Ìý 2013 No form 483 view report
Infarmed 2021 Ìý Ìý
Ìý 2020 Ìý Ìý
Ìý 2018 Ìý Ìý
Ìý 2017 Ìý Ìý
Ìý 2016 Ìý Ìý
Ìý 2016 Ìý Ìý
Ìý 2014 Ìý view report
Ìý 2013 Ìý view report
ANVISA 2019 Ìý Ìý
Ìý 2018 No observations Ìý
DGAV 2021 Ìý Ìý
Ìý 2018 Ìý Ìý
Ìý 2016 Ìý Ìý
Ìý 2015 Ìý Ìý
Russian FSBI VGNKI 2024 Ìý Ìý
Ìý 2021 Ìý Ìý
Russian HA 2022 Ìý Ìý
Ìý 2021 Ìý Ìý
Ìý 2017 Ìý Ìý
Russian MoIT 2022 Ìý Ìý
Ìý 2017 Ìý Ìý
Ìý 2017 Ìý Ìý
Turkey HA 2016 Ìý Ìý
MFDS 2021 No observations Ìý
KFDA 2013 Ìý Ìý

ANVISA - Brazil's National Health Surveillance Agency
DGAV - Portuguese Veterinary Products Authority
FDA - Food and Drug Administration
Infarmed -ÌýPortuguese Health Authority
KFDA - Ministry of Food and Drug Safety of the Republic of Korea
MFDS - Ministry of Food and Drug Safety of the Government of South Korea
Russian FSBI VGNKI - Russian Authority for Veterinary Products
Russian HA - Ministry of Health of the Russian Federation
Russian MoIT - Ministry of Industry and Trade of theÌýRussian Federation
Turkey HA - Turkish Medicines and Medical Devices Agency

Last inspections in New Jersey

Health Authority Date Observations Inspection Report
FDA 2022 No form 483 Ìý
Ìý 2021 Ìý Ìý
Ìý 2020 Ìý Ìý
Ìý 2015 Ìý view report
Ìý 2013 No form 483 view report
ANVISA 2024 Ìý Ìý
Ìý 2023 Ìý Ìý
Health Canada 2023 Ìý Ìý
PMDA 2022 Ìý Ìý
Ìý 2021 Ìý Ìý
SFDA 2023 Ìý Ìý
TGA 2023 Ìý Ìý

ANVISA - Brazil's National Health Surveillance Agency
FDA - Food and Drug Administration
PMDA - Pharmaceuticals and Medical Devices Agency of Japan
SFDA - Saudi Food & Drug Authority
TGA -ÌýTherapeutic Goods Administration

Ìý

Last inspections in Macau

Health Authority Date Observations Inspection Report
DAF 2021 Ìý Ìý
Ìý 2020 Ìý Ìý
Ìý 2019 Ìý Ìý
Ìý 2018 Ìý Ìý
Ìý 2017 Ìý Ìý
Ìý 2016 Ìý Ìý
Ìý 2014 Ìý Ìý
Ìý 2013 Ìý Ìý
FDA 2018 No form 483 Ìý
Ìý 2016 No form 483 view report
Ìý 2013 No form 483 view report
PMDA 2023 No observations Ìý
Ìý 2017 No critical or major observations Ìý
Infarmed 2015 No critical observations Ìý

DAF - Macau Health Bureau
FDA - Food and Drug Administration
Infarmed -ÌýPortuguese Health Authority
PMDA - Pharmaceuticals and Medical Devices Agency of Japan

Last inspections in Cork

Health Authority Date Observations Inspection Report
FDA 2023 No form 483 Ìý
Ìý 2017 No form 483 Ìý
Ìý 2016 Ìý view report
Ìý 2014 No form 483 view report
HPRA 2022 Ìý Ìý
Ìý 2019 Ìý Ìý
Ìý 2018 Ìý view report
Ìý 2015 Ìý view report
Ìý 2014 Ìý Ìý
Ìý 2013 Ìý Ìý
Russian HA 2017 Ìý Ìý
MFDS / KFDA 2015 Ìý Ìý
Tawain FDA 2020 Ìý Ìý
Ìý 2017 Ìý Ìý
Ìý 2015 Ìý Ìý

FDA - Food and Drug Administration
HPRA - Health ProductsÌýRegulatory Authority
KFDA - Ministry of Food and Drug Safety (MFDS) of the Republic of Korea
Russian HA - Ministry of Health of the Russian Federation

Ìý

Also in Quality

ËÄÉ«AV Policies

ËÄÉ«AV is dedicated to serving the Pharma Industry by providing services and products that save human lives and improve quality of life. Our team is fully committed to our Quality, HSEEn, HR and Innovation & Entrepreneurship policies.

Page